FI923527A - Förfarande för framställning av terapeutiskt användbara 3-piperidino-4-hydroxikromanderivat - Google Patents

Förfarande för framställning av terapeutiskt användbara 3-piperidino-4-hydroxikromanderivat Download PDF

Info

Publication number
FI923527A
FI923527A FI923527A FI923527A FI923527A FI 923527 A FI923527 A FI 923527A FI 923527 A FI923527 A FI 923527A FI 923527 A FI923527 A FI 923527A FI 923527 A FI923527 A FI 923527A
Authority
FI
Finland
Prior art keywords
piperidino
preparation
therapeutically useful
hydroxychroman
hydroxychroman derivatives
Prior art date
Application number
FI923527A
Other languages
English (en)
Finnish (fi)
Other versions
FI94957C (sv
FI94957B (sv
FI923527A0 (sv
Inventor
Todd W Butler
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI923527A publication Critical patent/FI923527A/sv
Publication of FI923527A0 publication Critical patent/FI923527A0/sv
Application granted granted Critical
Publication of FI94957B publication Critical patent/FI94957B/sv
Publication of FI94957C publication Critical patent/FI94957C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI923527A 1990-02-06 1992-08-05 Förfarande för framställning av terapeutiskt användbara 3-piperidino-4-hydroxikromanderivat FI94957C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9000674 1990-02-06
PCT/US1990/000674 WO1991012005A1 (en) 1990-02-06 1990-02-06 Neuroprotective 3-piperidino-4-hydroxychroman derivatives and analogs

Publications (4)

Publication Number Publication Date
FI923527A true FI923527A (sv) 1992-08-05
FI923527A0 FI923527A0 (sv) 1992-08-05
FI94957B FI94957B (sv) 1995-08-15
FI94957C FI94957C (sv) 1995-11-27

Family

ID=22220666

Family Applications (1)

Application Number Title Priority Date Filing Date
FI923527A FI94957C (sv) 1990-02-06 1992-08-05 Förfarande för framställning av terapeutiskt användbara 3-piperidino-4-hydroxikromanderivat

Country Status (29)

Country Link
US (1) US5356905A (sv)
EP (1) EP0441506B1 (sv)
JP (1) JPH0768214B2 (sv)
KR (1) KR930011041B1 (sv)
CN (1) CN1029960C (sv)
AT (1) ATE108787T1 (sv)
AU (1) AU626490B2 (sv)
BR (1) BR9100490A (sv)
CA (1) CA2035653C (sv)
CZ (1) CZ286218B6 (sv)
DE (2) DE69102893T4 (sv)
DK (1) DK0441506T3 (sv)
EG (1) EG19643A (sv)
ES (1) ES2056571T3 (sv)
FI (1) FI94957C (sv)
HU (1) HU222726B1 (sv)
IE (1) IE63836B1 (sv)
IL (1) IL97100A (sv)
MX (1) MX24433A (sv)
MY (1) MY105293A (sv)
NO (1) NO178399C (sv)
NZ (1) NZ237025A (sv)
PH (1) PH31061A (sv)
PL (1) PL164866B1 (sv)
PT (1) PT96664B (sv)
RU (1) RU2099339C1 (sv)
SK (1) SK281729B6 (sv)
WO (1) WO1991012005A1 (sv)
ZA (1) ZA91830B (sv)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5594007A (en) * 1991-04-18 1997-01-14 Pfizer Inc. Method for treating spinal cord trauma with phenolic 2-piperidino-1-alkanols
HUT65836A (en) * 1991-04-18 1994-07-28 Pfizer Process for producing phenol-esters of 1-(hydroxy-phenyl)-2-piperidino-1-alkanol derivatives and pharmaceutical compositions containing them
US5436255A (en) * 1992-07-23 1995-07-25 Pfizer Inc. Method of treating diseases susceptable to treatment by blocking NMDA-receptors
US5498610A (en) * 1992-11-06 1996-03-12 Pfizer Inc. Neuroprotective indolone and related derivatives
AU684568B2 (en) * 1994-01-31 1997-12-18 Pfizer Inc. Neuroprotective chroman compounds
ES2201106T3 (es) * 1994-08-18 2004-03-16 Pfizer Inc. Derivados neuroprotectores de 3-(piperidinil-1)-croman-4,7-diol y 1-(4-hidrofenil)-2-(piperidinil-1)-alcanol.
WO1996037226A2 (en) 1995-05-26 1996-11-28 Pfizer Inc. Combinations for the treatment of parkinsonism containing selective nmda antagonists
TW498067B (en) * 1996-07-19 2002-08-11 Hoffmann La Roche 4-hydroxy-piperidine derivatives
US6495561B2 (en) 1999-10-29 2002-12-17 Merck & Co., Inc. 2-cyclohexyl imidazopyridine NMDA/NR2B antagonists
US6291499B1 (en) 1999-10-29 2001-09-18 Merck & Co., Inc. 2-cyclohexyl benzimidazole NMDA/NR2B antagonists
US6432976B1 (en) 1999-10-29 2002-08-13 Merck & Co., Inc. 8-aza-bicyclo[3.2.1]octane NMDA/NR2B antagonists
US6380205B1 (en) 1999-10-29 2002-04-30 Merck & Co., Inc. 2-cyclohexyl quinazoline NMDA/NR2B antagonists
EP1235572A2 (en) 1999-10-29 2002-09-04 MERCK SHARP &amp; DOHME LTD. Method to treat pain utilizing benzimidazole nmda/nr2b antagonists
US6316474B1 (en) 1999-10-29 2001-11-13 Merck & Co., Inc. 2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists
US6476041B1 (en) 1999-10-29 2002-11-05 Merck & Co., Inc. 1,4 substituted piperidinyl NMDA/NR2B antagonists
US6369076B1 (en) 1999-10-29 2002-04-09 Merck & Co. Inc. 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline NMDA/NR2B antagonists
US6489477B1 (en) 1999-10-29 2002-12-03 Merck & Co., Inc. 2-aza-bicyclo[2.2.2]octane NMDA/NR2B antigonists
IL145209A0 (en) 2000-09-06 2002-06-30 Pfizer Prod Inc Pharmaceutical combinations for the treatment of stroke and traumatic brain injury
EP1674087A1 (en) 2000-10-02 2006-06-28 Pfizer Products Inc. Prophylactic use of n-methyl-d-aspartate (NMDA) antagonists
DK1379520T3 (da) 2001-02-23 2006-08-21 Merck & Co Inc N-substituerede ikke-aryl-heterocykliske NMDA/NR2B-antagonister
EP1390034A4 (en) 2001-04-03 2005-07-13 Merck & Co Inc NMDA / NR2B NONARYL-HETEROCYCLO AMIDYL N-SUBSTITUTE ANTAGONISTS
AU2004280256A1 (en) * 2003-10-08 2005-04-21 Organix, Inc. Pyrovalerone analogs and therapeutic uses thereof
DE602004028150D1 (de) * 2003-11-26 2010-08-26 Pfizer Prod Inc Aminopyrazolderivate als gsk-3-inhibitoren

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3294804A (en) * 1961-01-27 1966-12-27 Sterling Drug Inc 1-(3-hydroxy-3-phenylpropyl)-4-phenyl-4-propionoxy-piperidine
FR5733M (sv) * 1966-09-27 1968-01-22
GB1495526A (en) * 1974-05-31 1977-12-21 Beecham Group Ltd Chroman derivatives
DE2507782A1 (de) * 1975-02-22 1976-09-02 Merck Patent Gmbh Tetralon- und indanon-derivate sowie verfahren zu ihrer herstellung
US4016281A (en) * 1975-02-22 1977-04-05 Merck Patent Gesellschaft Mit Beschrankter Haftung Tetralone and indanone compounds
GB2107706A (en) * 1981-09-25 1983-05-05 Beecham Group Plc Benzopyrans
EP0093534A1 (en) * 1982-04-28 1983-11-09 Beecham Group Plc Novel chromanols
GB8308064D0 (en) * 1983-03-24 1983-05-05 Beecham Group Plc Active compounds

Also Published As

Publication number Publication date
NO923081D0 (no) 1992-08-05
CS25091A3 (en) 1991-09-15
CA2035653C (en) 1999-12-21
PL288949A1 (en) 1991-07-29
NZ237025A (en) 1992-11-25
EP0441506A3 (en) 1991-11-21
IL97100A (en) 1996-06-18
WO1991012005A1 (en) 1991-08-22
KR930011041B1 (ko) 1993-11-20
IL97100A0 (en) 1992-03-29
RU2099339C1 (ru) 1997-12-20
AU626490B2 (en) 1992-07-30
ZA91830B (en) 1992-09-30
PH31061A (en) 1998-02-05
DE69102893D1 (de) 1994-08-25
PT96664B (pt) 1998-07-31
IE63836B1 (en) 1995-06-14
JPH0768214B2 (ja) 1995-07-26
EP0441506A2 (en) 1991-08-14
EG19643A (en) 1995-09-30
CN1029960C (zh) 1995-10-11
AU7029391A (en) 1991-09-05
MY105293A (en) 1994-09-30
FI94957C (sv) 1995-11-27
DE69102893T2 (de) 1994-11-03
HU222726B1 (hu) 2003-09-29
MX24433A (es) 1993-05-01
SK281729B6 (sk) 2001-07-10
US5356905A (en) 1994-10-18
KR910015568A (ko) 1991-09-30
FI94957B (sv) 1995-08-15
DE9101346U1 (de) 1991-06-06
CN1053923A (zh) 1991-08-21
ATE108787T1 (de) 1994-08-15
CA2035653A1 (en) 1991-08-07
IE910372A1 (en) 1991-08-14
NO178399B (no) 1995-12-11
PL164866B1 (pl) 1994-10-31
BR9100490A (pt) 1991-10-29
CZ286218B6 (cs) 2000-02-16
NO923081L (no) 1992-08-05
PT96664A (pt) 1991-10-31
EP0441506B1 (en) 1994-07-20
NO178399C (no) 1996-03-20
FI923527A0 (sv) 1992-08-05
DE69102893T4 (de) 1995-08-10
ES2056571T3 (es) 1994-10-01
JPH04211058A (ja) 1992-08-03
DK0441506T3 (da) 1994-09-05

Similar Documents

Publication Publication Date Title
FI923527A (sv) Förfarande för framställning av terapeutiskt användbara 3-piperidino-4-hydroxikromanderivat
MD1761B2 (ro) Eteri de 2,6-dihidroxipiridină, procedeu de preparare a lor, compoziţie erbicidă şi metodă de combatere a creşterii plantelor indezirabile
MX9700273A (es) Benzamidinas sustituidas, su preparacion y empleo como sustancias medicamentosas.
AU580728B2 (en) Novel carbacyclins, process for their manufacture and their use as medicaments
HU9301931D0 (en) Process for the production of azabicyclo [2.2.2] octane-3-imines and thereof inrtermediers
JPS53137905A (en) Preparation of polyol ether
HUT62581A (en) Process for producing pipeidine derivatives and pharmaceutical compositions comprising such compounds
GR3019711T3 (en) Spiro-indoline-oxazine compounds with photochromatic and photosensitizing characteristics and the process for their preparation
JPS57118570A (en) Novel 3-phenyl-4-quinazolone derivative
JPS52105141A (en) Preparation of perfluorononenyloxybenzoic acid
CA2055174A1 (en) Process for the synthesis of alpha-((dialkylamino) substituted-methylene)-beta-oxo-(substituted) propanenitriles
JPS55104273A (en) 4-phenylisoxazole derivative and its preparation
JPS5368790A (en) Preparation of 1-(2&#39;-tetrahydrofuryl)-5-fluorouracil
ES479233A1 (es) Procedimiento para la obtencion de derivados de antraquinona.
MY124079A (en) Process for producing 1, 2-dimethyl-3-hydroxypyrid-4- one
ES8400410A1 (es) Procedimiento para la preparacion de nuevas sulfiminas.
IT1240644B (it) Derivati polifosfazenici contenenti gruppi azobenzenici atti all&#39; impiego come materiali a caratteristiche fotocromiche
JPS51128493A (en) A process for preparing optically active amino acids
JPS5368791A (en) Preparation of 1-(2&#39;-tetrahydrofuryl)-5-fluorouracil
JPS52143287A (en) Mocrobial production of b-methyl-l-norleucine
JPS51149254A (en) A process for preparing 3-endo-hydroxy- endo-tricyclo(5.2.2.02.6)undec a-8-en
MX9605668A (es) Sal de estilbazolio, su preparacion y uso.
JPS5217474A (en) Process for preparation of 4-carboxy-3, 4-dihydroisocoumarin
JPS5535024A (en) Novel method of production of 3&#39;,4&#39;-dideoxy-6&#39;-n-methylkanamycin b
JPS51122032A (en) Process for preparation of 2-phenyl propyl alcohol

Legal Events

Date Code Title Description
BB Publication of examined application